Results 211 to 220 of about 129,482 (378)
Experimental oligocythaemia and splenomegaly
, 1939 John Mellanby, S. F. Suffolk
openalex +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.New‐onset DM occurred in 13% of patients with AIH, was related to older age, non‐Caucasian ethnicity, higher prednisolone dose, higher BMI at diagnosis and weight gain and was an independent predictor of all‐cause death/transplantation and of cirrhosis development, underlining the need to minimise steroid burden in AIH.
Sarah Flatley +6 more
wiley +1 more source
Anæmia with Splenomegaly [PDF]
Proceedings of the Royal Society of Medicine, 1940 openaire +4 more sources
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
British Journal of Haematology, EarlyView.Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan +2 more
wiley +1 more source
A Very Hairy Case: Marked Leukocytosis in Hairy Cell Leukaemia. [PDF]
EJHaemeJHaem, Volume 6, Issue 3, June 2025.
Kennedy SJ, van Marle AC.
europepmc +2 more sources
The Significance of Splenomegaly in Tumour-Bearing Mice [PDF]
, 1962 M. F. A. Woodruff, M O Symes
openalex +1 more source
Iron overload in hereditary spherocytosis: Are genetic factors the cause?
British Journal of Haematology, EarlyView.Summary Non‐transfusional iron overload (IOL) in hereditary spherocytosis (HS) is poorly documented compared with other red blood cell disorders. We studied 13 HS adults with confirmed IOL to identify potential genetic factors. Using a next‐generation sequencing panel of 46 genes related to HS, anaemia and iron metabolism, we found no association ...
Lucie Donaty +6 more
wiley +1 more source
Childhood splenomegaly in Uganda, and its relation to malaria. [PDF]
, 1968 T. M. Vanier, M. S. R. Hutt, Gordon Cook
openalex +1 more source